This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shinke, T. Articles by Yokoyama, M. Search for Related Content PubMed PubMed Citation Articles by Shinke, T. Articles by Yokoyama, M. Related Collections Congestive Myocardial cardiomyopathy disease

(Circulation. 2000;101:1925.)
© 2000 American Heart Association, Inc.

Clinical Investigation and Reports

Nitric Oxide Spares Myocardial Oxygen Consumption Through Attenuation of Contractile Response to ß-Adrenergic Stimulation in Patients With Idiopathic Dilated Cardiomyopathy

Toshiro Shinke, MD; Hideyuki Takaoka, MD; Motoshi Takeuchi, MD; Katsuya Hata, MD; Hiroya Kawai, MD; Hideaki Okubo, MD; Yoichi Kijima, MD; Takeomi Murata, MD; Mitsuhiro Yokoyama, MD

From the First Department of Internal Medicine Kobe University School of Medicine, Kobe, Japan.

Correspondence to Hideyuki Takaoka, MD, First Department of Internal Medicine, Kobe University School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe 6500017, Japan.

Background—The results of recent studies suggest that NO synthase may increase in the failing myocardium and that NO modulates the myocardial contractile response to ß-adrenergic stimulation. However, there are few data regarding the physiological role of NO in patients with heart failure. The aim of the present study was to address the role of NO in left ventricular (LV) contractile response to ß-adrenergic stimulation and corresponding oxygen expenditure in human heart failure.

Methods and Results—We studied 15 patients with heart failure due to idiopathic dilated cardiomyopathy (mean ejection fraction 0.33). We examined LV contractility (E_max, the slope of end-systolic pressure-volume relation), LV external work (EW), myocardial oxygen consumption (MO₂), and mechanical efficiency (measured as EW/MO₂) with the use of conductance and coronary sinus thermodilution catheters before and during dobutamine (DOB) infusion via a peripheral vein (4.8±0.3 µg · kg^-1 · min^-1 IV). Heart rate was kept constant with atrial pacing. We carried out a similar protocol during the intracoronary infusion of the NO synthase inhibitor N^G-monomethyl-L-arginine (L-NMMA; 200 µmol). DOB increased E_max, EW, and MO₂ (by 77±17%, 39±5%, and 21±5%, respectively), leading to an increase in mechanical efficiency (25.4±3.1% to 29.6±4.1%). L-NMMA alone did not significantly change these variables. Although the concurrent infusion of DOB with L-NMMA increased E_max, EW, and MO₂ (by 140±21%, 64±9%, and 35±5%, respectively) more than DOB alone, mechanical efficiency did not increase further (24.3±3.3% to 29.5±4.5%) because EW and MO₂ increased in parallel.

Conclusions—These data suggest that in patients with idiopathic dilated cardiomyopathy, endogenous NO spares MO₂ through attenuation of LV contractile response to ß-adrenergic stimulation while maintaining LV energy-converting efficiency.

Key Words: heart failure • nitric oxide • contractility • oxygen

This article has been cited by other articles:

				D. Nordhaug, T. Steensrud, E. Aghajani, C. Korvald, and T. Myrmel Nitric oxide synthase inhibition impairs myocardial efficiency and ventriculo-arterial matching in acute ischemic heart failure Eur J Heart Fail, October 1, 2004; 6(6): 705 - 713. [Abstract] [Full Text] [PDF]

				W. J. Paulus and J. G. F. Bronzwaer Nitric oxide's role in the heart: control of beating or breathing? Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H8 - H13. [Abstract] [Full Text] [PDF]

				S. Mak and G. E. Newton Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H789 - H795. [Abstract] [Full Text] [PDF]

				A. M. Feldman The emerging role of pharmacogenomics in the treatment of patients with heart failure Ann. Thorac. Surg., December 1, 2003; 76(6): S2246 - 2253. [Full Text] [PDF]

				P.B. Massion, O. Feron, C. Dessy, and J.-L. Balligand Nitric Oxide and Cardiac Function: Ten Years After, and Continuing Circ. Res., September 5, 2003; 93(5): 388 - 398. [Abstract] [Full Text] [PDF]

				Z. Z. Kojic, U. Flogel, J. Schrader, and U. K. M. Decking Endothelial NO formation does not control myocardial O2 consumption in mouse heart Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H392 - H397. [Abstract] [Full Text] [PDF]

				K. Kumar, K. Nguyen, S. Waxman, B. D. Nearing, G. A. Wellenius, S. X. Zhao, and R. L. Verrier Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart J. Am. Coll. Cardiol., May 21, 2003; 41(10): 1831 - 1837. [Abstract] [Full Text] [PDF]

				N. Paolocci, T. Katori, H. C. Champion, M. E. St. John, K. M. Miranda, J. M. Fukuto, D. A. Wink, and D. A. Kass From the Cover: Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: Independence from beta -adrenergic signaling PNAS, April 29, 2003; 100(9): 5537 - 5542. [Abstract] [Full Text] [PDF]

				D. M. McNamara, R. Holubkov, L. Postava, R. Ramani, K. Janosko, M. Mathier, G. A. MacGowan, S. Murali, A. M. Feldman, and B. London Effect of the Asp298 Variant of Endothelial Nitric Oxide Synthase on Survival for Patients With Congestive Heart Failure Circulation, April 1, 2003; 107(12): 1598 - 1602. [Abstract] [Full Text] [PDF]

				D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]

				Y. Chen, J. H. Traverse, R. Du, M. Hou, and R. J. Bache Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart Circulation, July 9, 2002; 106(2): 273 - 279. [Abstract] [Full Text] [PDF]

				J. H. Traverse, Y. Chen, M. Hou, and R. J. Bache Inhibition of NO production increases myocardial blood flow and oxygen consumption in congestive heart failure Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2278 - H2283. [Abstract] [Full Text] [PDF]

				L. A. Nikolaidis, T. Hentosz, A. Doverspike, R. Huerbin, C. Stolarski, Y.-T. Shen, and R. P. Shannon Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2270 - H2281. [Abstract] [Full Text] [PDF]

				H. Post, R. Schulz, P. Gres, and G. Heusch No involvement of nitric oxide in the limitation of beta -adrenergic inotropic responsiveness during ischemia Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2392 - H2397. [Abstract] [Full Text] [PDF]

				J. M. Cotton, M. T. Kearney, P. A. MacCarthy, R. M. Grocott-Mason, D. R. McClean, C. Heymes, P. J. Richardson, and A. M. Shah Effects of Nitric Oxide Synthase Inhibition on Basal Function and the Force-Frequency Relationship in the Normal and Failing Human Heart In Vivo Circulation, November 6, 2001; 104(19): 2318 - 2323. [Abstract] [Full Text] [PDF]

				I. S. Wittstein, D. A. Kass, P. H. Pak, W. L. Maughan, B. Fetics, and J. M. Hare Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., August 1, 2001; 38(2): 429 - 435. [Abstract] [Full Text] [PDF]